US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Eledon Pharmaceuticals Inc (ELDN)
Eledon Pharmaceuticals Inc (ELDN) ニュース

ELDN

Eledon Pharmaceuticals (ELDN)

Eledon Pharmaceuticals Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ELDN

1 2 3 4 5 6 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/15	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/06/15	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/06/15	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/06/15	06 : 00	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/06/07	05 : 01	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/06/06	13 : 15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/06/04	05 : 01	GlobeNewswire Inc.	Eledon Presents Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/31	05 : 25	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/31	05 : 05	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/25	05 : 02	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/15	20 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/14	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/09	20 : 30	GlobeNewswire Inc.	Eledon Pharmaceuticals Reports First Quarter 2024 Operating and Financial Results	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/09	20 : 00	GlobeNewswire Inc.	Eledon Pharmaceuticals to Present Updated Data from Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation at the American Transplant Congress	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/07	20 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/07	20 : 05	GlobeNewswire Inc.	Eledon Announces Clinical Progress with Tegoprubart in the Prevention of Transplant Rejection	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/05/07	20 : 00	GlobeNewswire Inc.	Eledon Pharmaceuticals Announces Oversubscribed $50 Million Private Placement	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/03/29	05 : 01	GlobeNewswire Inc.	Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/03/26	05 : 56	GlobeNewswire Inc.	Eledon Pharmaceuticals Announces 12th Participant Enrolled in Phase 2 BESTOW Trial Evaluating Tegoprubart for the Prevention of Organ Rejection	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/03/21	23 : 31	GlobeNewswire Inc.	Eledon Pharmaceuticals Announces Use of Tegoprubart in First-ever Transplant of Genetically Modified Kidney from a Pig to a Human	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/02/15	05 : 35	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/02/15	05 : 01	Edgar (US Regulatory)	Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/02/14	09 : 01	GlobeNewswire Inc.	Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2024/01/05	06 : 40	GlobeNewswire Inc.	Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2024 Outlook	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/12/05	08 : 00	GlobeNewswire Inc.	Eledon Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/11/30	06 : 05	GlobeNewswire Inc.	Eledon Pharmaceuticals to Present at Noble Capital Markets' Emerging Growth Equity Conference	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/11/10	07 : 00	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/11/10	06 : 01	GlobeNewswire Inc.	Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/11/09	06 : 05	GlobeNewswire Inc.	Eledon Pharmaceuticals to Present at Jefferies London Healthcare Conference	NASDAQ:ELDN	Eledon Pharmaceuticals Inc
2023/11/03	05 : 30	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:ELDN	Eledon Pharmaceuticals Inc

Showing the most relevant articles for your search:NASDAQ:ELDN

1 2 3 4 5 6 次へ >>

Invesco EQQQ Nasdaq100 U...

Hsbc Usa Inc Autocallabl...

AuvergneRhneAlpes 0% unt...

Mytilineos (PK)

Boc Hong Kong (PK)

Mineral Hill Industries

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約